使用时间变化的模型预测肝硬化患者的长期存活率
David Goldberg1,2, Yalda Zarnegarnia2
1Department of Medicine, Division of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA.
Hepatology communications
|June 6, 2023
概括
这项研究使用时间变化的数据开发了一种新的肝硬化生存预测模型. 该模型在预测患者几年生存率方面表现出色的准确性,改善了临床决策.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 医疗信息学 医疗信息学
- 生物统计学 生物统计学
背景情况:
- 传统的肝硬化风险预测模型侧重于短期死亡率.
- 现有的模型在仅使用基线数据预测长期生存方面存在局限性.
研究的目的:
- 开发和验证一种时间更新的肝硬化生存风险预测模型.
- 改善肝硬化患者中期和长期生存预测.
主要方法:
- 利用扩展的Cox模型与来自OneFlorida临床研究联盟的时间变化的实验室和临床数据.
- 使用完整案例分析和缺失数据的归算进行评估模型的歧视和校准.
- 包括人口统计,时间更新实验室 (白蛋白,AST,ALP,白血素,血小板,) 和临床变量 (,脑病,SBP,静脉动脉).
主要成果:
- 在完整案例分析中,最终模型在1至5年的时间点显示出优异的歧视 (AUC和C指数>0.85).
- 模型的性能仍然很好 (C指数>0.8),即使对缺少的实验室数据进行了归算.
- 排除种族和种族并没有影响模型性能.
结论:
- 为肝硬化生存开发了一个时间更新模型,并在内部验证,具有出色的预测歧视.
- 这种模型可能会优于现有的风险评分,提供更好的患者咨询和临床决策支持.
- 建议进行外部验证,以确认其在不同患者群体中的实用性.
相关概念视频
Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
Assumptions of Survival Analysis
160
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
160
Actuarial Approach
101
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
101
Kaplan-Meier Approach
197
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
197
Comparing the Survival Analysis of Two or More Groups
228
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
228
Introduction To Survival Analysis
301
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
301


